FCV vs PCV in Moderate to Severe ARDS
NCT: NCT06051188 · TERMINATED
Brief Summary
The goal of this clinical trial is to compare flow-controlled ventilation (FCV) and pressure-controlled ventilation (PCV) in patients with moderate to severe acute respiratory distress syndrome on the intensive care unit. The main questions it aims to answer are: * Is the mechanical power during flow-controlled ventilation lower than during pressure-controlled ventilation * To gain more understanding about other physiological effects and potential benefits of flow-controlled ventilation in comparison to pressure-controlled ventilation (o.a. the end-expiratory lung volume and homogeneity of ventilation). Participants will be randomized between two ventilation mode sequences, being 90 minutes of FCV followed by 90 minutes of PCV or vice versa.
Frequently Asked Questions
What is FCV vs PCV in Moderate to Severe ARDS?
FCV vs PCV in Moderate to Severe ARDS is a clinical trial registered under NCT06051188. Current status: TERMINATED.
What is the status of NCT06051188?
The current status of NCT06051188 (FCV vs PCV in Moderate to Severe ARDS) is: TERMINATED.
When did FCV vs PCV in Moderate to Severe ARDS start?
FCV vs PCV in Moderate to Severe ARDS started on 2023-09-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.